Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Total Liabilities : ¥2,278 Mil (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Total Liabilities?

Tonghua Golden-horse Pharmaceutical Industry Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥2,278 Mil.

Tonghua Golden-horse Pharmaceutical Industry Co's quarterly Total Liabilities increased from Sep. 2023 (¥2,148.44 Mil) to Dec. 2023 (¥2,201.12 Mil) and increased from Dec. 2023 (¥2,201.12 Mil) to Mar. 2024 (¥2,277.73 Mil).

Tonghua Golden-horse Pharmaceutical Industry Co's annual Total Liabilities increased from Dec. 2021 (¥2,301.48 Mil) to Dec. 2022 (¥2,316.61 Mil) but then declined from Dec. 2022 (¥2,316.61 Mil) to Dec. 2023 (¥2,201.12 Mil).

Tonghua Golden-horse Pharmaceutical Industry Co Total Liabilities Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Total Liabilities Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,032.06

2,675.97

2,301.48

2,316.61

2,201.12

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															2,125.30	2,155.33	2,148.44	2,201.12	2,277.73

Tonghua Golden-horse Pharmaceutical Industry Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tonghua Golden-horse Pharmaceutical Industry Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	572.493	+	(1559.511	+	69.113
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,201

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	4519.244	-	2318.127
	=	2,201

Tonghua Golden-horse Pharmaceutical Industry Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	641.572	+	(1569.007	+	67.149
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,278

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	4605.021	-	2327.293
	=	2,278

Tonghua Golden-horse Pharmaceutical Industry Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001

Website

http://www.thjm.cn

Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.

Executives

Wei Ying Jie	Director
Zan Bao Shi	Director
Wu Cheng Yu	Directors, executives
Zhang De Ju	Supervisors
Li Ju	Supervisors
Feng Ran	Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines